Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5ZFH

Mouse Kallikrein 7

Summary for 5ZFH
Entry DOI10.2210/pdb5zfh/pdb
DescriptorKallikrein-7 (2 entities in total)
Functional Keywordsprotease, hydrolase
Biological sourceMus musculus (Mouse)
Total number of polymer chains1
Total formula weight24637.33
Authors
Sugawara, H. (deposition date: 2018-03-06, release date: 2018-06-27, Last modification date: 2024-10-16)
Primary citationMurafuji, H.,Sugawara, H.,Goto, M.,Oyama, Y.,Sakai, H.,Imajo, S.,Tomoo, T.,Muto, T.
Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones.
Bioorg. Med. Chem., 26:3639-3653, 2018
Cited by
PubMed Abstract: A series of 1,3,6-trisubstituted 1,4-diazepan-7-ones were prepared as kallikrein 7 (KLK7, stratum corneum chymotryptic enzyme) inhibitors. Previously reported compounds 1-3 were potent human KLK7 inhibitors; however, they did not exhibit inhibitory activity against mouse KLK7. Comparison of the human and mouse KLK7 structures reveals the cause of this species differences; therefore, compounds that could inhibit both KLK7s were designed, synthesized, and evaluated. Through this structure-based drug design, compound 22g was identified as an inhibitor against human and mouse KLK7, and only one of the enantiomers, (-)-22g, exhibited potent inhibitory activity. Furthermore, the crystal structure of mouse KLK7 complexed with 22g enabled the elucidation of structure-activity relationships and justified 22g as a valuable compound to overcome the species differences.
PubMed: 29884582
DOI: 10.1016/j.bmc.2018.05.044
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.93 Å)
Structure validation

238268

건을2025-07-02부터공개중

PDB statisticsPDBj update infoContact PDBjnumon